NEETPGAI
FeaturesNEET PGFMGEINI-CETBlogPricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Features
  • Subjects
  • Previous Year Questions
  • NEET PG Preparation
  • FMGE Preparation
  • INI-CET Preparation
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Contact & support

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Pathology/Thyroid Neoplasms
    Thyroid Neoplasms
    medium
    microscope Pathology

    A 52-year-old woman from Delhi presents with a solitary thyroid nodule (2.5 cm) detected on routine ultrasound. Fine-needle aspiration cytology (FNAC) shows follicular neoplasm (Bethesda Category III). Thyroid function tests are normal. What is the most appropriate next step in management?

    A. Observation with ultrasound surveillance every 6 months
    B. Total thyroidectomy followed by radioactive iodine ablation
    C. Repeat FNAC in 3 months
    D. Thyroid lobectomy with intraoperative frozen section

    Explanation

    Clinical Context

    A Bethesda Category III (atypia of undetermined significance / follicular neoplasm) result on FNAC carries a 15–30% risk of malignancy. The nodule is 2.5 cm (>2 cm), which increases suspicion. Repeat FNAC has poor sensitivity and delays diagnosis; observation alone is inappropriate given the size and cytology.

    Management Algorithm for Bethesda III Nodules

    Loading diagram...

    Key Point:

    Thyroid lobectomy with intraoperative frozen section is the gold standard for Bethesda III nodules >2 cm. This approach:

    • Provides definitive histology (frozen section)
    • Allows completion thyroidectomy if malignancy is confirmed
    • Avoids unnecessary total thyroidectomy if benign
    • Minimizes morbidity (single-stage surgery if benign)

    High-Yield:

    Bethesda Category III carries 15–30% malignancy risk. Size >2 cm warrants surgical evaluation rather than repeat cytology or observation alone.

    Clinical Pearl:

    Molecular testing (ThyroSeq, Afirma) can help refine risk in Bethesda III, but in a resource-limited setting or when unavailable, lobectomy with frozen section remains the standard of care in India.

    Loading illustration…Thyroid Neoplasms diagram

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Pathology Questions

    Join our NEET PG community

    Daily MCQs, study tips, and topper strategies on Telegram.

    Join on Telegram →